Free Access
Issue
Reprod. Nutr. Dev.
Volume 45, Number 5, September-October 2005
Page(s) 613 - 631
DOI https://doi.org/10.1051/rnd:2005049
References of Reprod. Nutr. Dev. 45 613-631
  1. Farooqui AA, Horrocks LA, Farooqui T. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem Phys Lipids 2000, 106: 1-29 [CrossRef] [PubMed].
  2. Fraschini A, Fuhrman Conti AM. Nuclear phospholipids during the adaptation of human EUE cells to hypertonic stress. Histochem Cell Biol 1995, 103: 47-57 [CrossRef] [PubMed].
  3. Albi E, Micheli M, Viola-Magni MP. Phospholipids and nuclear RNA. Cell Biol Int 1996, 20: 407-412 [CrossRef] [PubMed].
  4. Hunt AN, Clark GT, Attard GS, Postle AD. Highly saturated endonuclear phosphatidylcholine is synthesized in situ and colocated with CDP-choline pathway enzymes. J Biol Chem 2001, 276: 8492-8499 [CrossRef] [PubMed].
  5. Irvine RF. Nuclear lipid signalling. Nature Rev Mol Cell Biol 2003, 4: 349-360.
  6. Farooqui AA, Farooqui T, Horrocks LA. Molecular species of phospholipids during brain development. Their occurrence, separation and roles. In: Skinner ER (Ed), Brain Lipids and Disorders in Biological Psychiatry, Elsevier Science BV, Amsterdam, 2002, p 147-158.
  7. Fraschini A, Biggiogera M, Bottone MG, Martin TE. Nuclear phospholipids in human lymphocytes activated by phytohemagglutinin. Eur J Cell Biol 1999, 78: 416-423 [PubMed].
  8. Tamiya-Koizumi K. Nuclear lipid metabolism and signaling. J Biochem 2002, 132: 13-22 [PubMed].
  9. Martelli AM, Manzoli L, Cocco L. Nuclear inositides: facts and perspectives. Pharmacol Ther 2004, 101: 47-64 [CrossRef] [PubMed].
  10. Ledeen RW, Wu GS. Nuclear lipids: key signaling effectors in the nervous system and other tissues. J Lipid Res 2004, 45: 1-8 [PubMed].
  11. Haddad JJ. On the antioxidant mechanisms of Bcl-2: a retrospective of NF-$\kappa$B signaling and oxidative stress. Biochem Biophys Res Commun 2004, 322: 355-363 [CrossRef] [PubMed].
  12. Lang D, Leray C, Mestre R, Massarelli R, Dreyfus H, Freysz L. Molecular species analysis of 1,2-diglycerides on phorbol ester stimulation of LA-N-1 neuroblastoma cells during proliferation and differentiation. J Neurochem 1995, 65: 810-817 [PubMed].
  13. D'Santos CS, Clarke JH, Divecha N. Phospholipid signalling in the nucleus. Biochim Biophys Acta Lipids Lipid Metab 1998, 1436: 201-232.
  14. Martelli AM, Capitani S, Neri LM. The generation of lipid signaling molecules in the nucleus. Prog Lipid Res 1999, 38: 273-308 [CrossRef] [PubMed].
  15. Cocco L, Martelli AM, Gilmour RS, Rhee SG, Manzoli FA. Nuclear phospholipase C and signaling. Biochim Biophys Acta Mol Cell Biol Lipids 2001, 1530: 1-14.
  16. Maraldi NM, Zini N, Santi S, Manzoli FA. Topology of inositol lipid signal transduction in the nucleus. J Cell Physiol 1999, 181: 203-217 [CrossRef] [PubMed].
  17. Martelli AM, Manzoli L, Faenza I, Bortul R, Billi A, Cocco L. Nuclear inositol lipid signaling and its potential involvement in malignant transformation. Biochim Biophys Acta 2002, 1603: 11-17 [PubMed].
  18. Martelli AM, Bortul R, Tabellini G, Bareggi R, Manzoli L, Narducci P, Cocco L. Diacylglycerol kinases in nuclear lipid-dependent signal transduction pathways. Cell Mol Life Sci 2002, 59: 1129-1137 [CrossRef] [PubMed].
  19. Antony P, Kanfer JN, Freysz L. Phosphatidylcholine metabolism in nuclei of phorbol ester activated LA-N-1 neuroblastoma cells. Neurochem Res 2000, 25: 1073-1082 [CrossRef] [PubMed].
  20. Hammond G, Thomas CL, Schiavo G. Nuclear phosphoinositides and their functions. In: Stenmark H (Ed), Phosphoinositides in Subcellular Targeting and Enzyme Activation, Springer-Verlag Berlin, Berlin, 2004, p 177-206.
  21. Martelli AM, Tabellini G, Borgatti P, Bortul, R Capitani S, Neri LM. Nuclear lipids: New functions for old molecules? J Cell Biochem 2003, 88: 455-461 [CrossRef] [PubMed].
  22. Cocco L, Manzoli L, Barnabei O, Martelli AM. Significance of subnuclear localization of key players of inositol lipid cycle. In: Weber G (Ed), Advances in Enzyme Regulation, Vol 44, Elsevier Science B V, Amsterdam, 2004, p 51-60.
  23. Antony, P Freysz L, Horrocks LA, Farooqui AA. Effect of retinoic acid on the Ca2+-independent phospholipase A2 in nuclei of LA-N-1 neuroblastoma cells. Neurochem Res 2001, 26: 83-88 [CrossRef] [PubMed].
  24. Antony P, Freysz L, Horrocks LA, Farooqui AA. Ca2+-independent phospholipases A2 and production of arachidonic acid in nuclei of LA-N-1 cell cultures: a specific receptor activation mediated with retinoic acid. Brain Res Mol 2003, 115: 187-195.
  25. Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbol ester-induced differentiation. Cell Differ 1984, 14: 135-144 [CrossRef] [PubMed].
  26. Sidell N, Altman A, Haussler MR, Seeger RC. Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp Cell Res 1983, 148: 21-30 [CrossRef] [PubMed].
  27. Prasad KN. Differentiation of neuroblastoma cells in culture. Biol Rev Camb Philos Soc 1975, 50: 129-165 [PubMed].
  28. Farooqui AA, Ong WY, Horrocks LA, Farooqui T. Brain cytosolic phospholipase A2: Localization, role, and involvement in neurological diseases. Neuroscientist 2000, 6: 169-180.
  29. Farooqui AA, Yang HC, Rosenberger TA, Horrocks LA. Phospholipase A2 and its role in brain tissue. J Neurochem 1997, 69: 889-901 [PubMed].
  30. Farooqui AA, Antony P, Ong WY, Horrocks LA, Freysz L. Retinoic acid-mediated phospholipase A2 signaling in the nucleus. Brain Res Rev 2004, 45: 179-195 [CrossRef].
  31. Misra UK, Pizzo SV. Cytosolic phospholipase A2 activity associated with nuclei is not inhibited by arachidonyl trifluoromethyl ketone in macrophages stimulated with receptor-recognized forms of $\alpha$2-macroglobulin. Arch Biochem Biophys 2000, 379: 153-160 [CrossRef] [PubMed].
  32. Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002, 68-69: 3-58 [PubMed].
  33. Sun GY, Xu J, Jensen MD, Simonyi A. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 2004, 45: 205-213 [PubMed].
  34. Molloy GY, Rattray M, Williams RJ. Genes encoding multiple forms of phospholipase A2 are expressed in rat brain. Neurosci Lett 1998, 258: 139-142 [CrossRef] [PubMed].
  35. Zanassi P, Paolillo M, Schinelli S. Coexpression of phospholipase A2 isoforms in rat striatal astrocytes. Neurosci Lett 1998, 247: 83-86 [CrossRef] [PubMed].
  36. Yang HC, Mosior M, Ni B, Dennis EA. Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain. J Neurochem 1999, 73: 1278-1287 [CrossRef] [PubMed].
  37. Balboa MA, Varela-Nieto I, Lucas KK, Dennis EA. Expression and function of phospholipase A2 in brain. FEBS Lett 2002, 531: 12-17 [CrossRef] [PubMed].
  38. Suburo A, Cei de Job C. The biphasic effect of phospholipase A2 inhibitors on axon elongation. Int J Dev Neurosci 1986, 4: 363-367 [CrossRef] [PubMed].
  39. Smalheiser NR, Dissanayake S, Kapil A. Rapid regulation of neurite outgrowth and retraction by phospholipase A2-derived arachidonic acid and its metabolites. Brain Res 1996, 721: 39-48 [CrossRef] [PubMed].
  40. Berlin RD, Preston SF. Arachidonic acid mobilization is suppressed during mitosis: role of cytosolic phospholipase A2 activation. Biochem J 1995, 309: 91-97 [PubMed].
  41. Korystov YN, Shaposhnikova VV, Levitman MK, Kudryavtsev AA, Kublik LN, Narimanov AA, Orlova OE. The effect of inhibitors of arachidonic acid metabolism on proliferation and death of tumor cells. FEBS Lett 1998, 431: 224-226 [CrossRef] [PubMed].
  42. Van Rossum GSAT, Bijvelt JJM, van den Bosch H, Verkleij AJ, Boonstra J. Cytosolic phospholipase A2 and lipoxygenase are involved in cell cycle progression in neuroblastoma cells. Cell Mol Life Sci 2002, 59: 181-188 [CrossRef] [PubMed].
  43. Wissing D, Mouritzen H, Egeblad M, Poirier GG, Jäättelä M. Involvement of caspase-dependent activation of cytosolic phospholipase 2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci USA 1997, 94: 5073-5077 [CrossRef] [PubMed].
  44. Pirianov G, Danielsson C, Carlberg C, James SY, Colston KW. Potentiation by vitamin D analogs of TNF$\alpha$ and ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2. Cell Death Differ 1999, 6: 890-901 [CrossRef] [PubMed].
  45. Zupan LA, Weiss RH, Hazen SL, Parnas BL, Aston KW, Lennon PJ, Getman DP, Gross RW. Structural determinants of haloenol lactone-mediated suicide inhibition of canine myocardial calcium-independent phospholipase A2. J Medicinal Chem 1993, 36: 95-100.
  46. Shinzawa K, Tsujimoto Y. PLA2 activity is required for nuclear shrinkage in caspase-independent cell death. J Cell Biol 2003, 163: 1219-1230 [CrossRef] [PubMed].
  47. Ahlemeyer B, Krieglstein J. Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine-induced oxidative stress and apoptosis. Neurochem Int 2000, 36: 1-5 [CrossRef] [PubMed].
  48. Tong L, Werrbach-Perez K, Perez-Polo, JR. Retinoic acid induces apoptosis in PC12 cells independent of neurotrophic factors. J Neurochem 1997, 68: 1424-1435 [PubMed].
  49. Farooqui AA, Ong WY, Horrocks LA. Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2. Neurochem Res 2004, 29: 1961-1977 [CrossRef] [PubMed].
  50. Zhang H, Satyamoorthy K, Herlyn M, Rosdahl I. All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells - a speculation on damage effect of atRA via mitochondrial dysfunction and cell cycle redistribution. Carcinogenesis 2003, 24: 185-191 [CrossRef] [PubMed].
  51. Jump DB. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 2002, 13: 155-164 [CrossRef] [PubMed].
  52. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 2004, 41: 41-78 [PubMed].
  53. Balmer JE, Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 2002, 43: 1773-1808 [PubMed].
  54. Levine L. Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors. Prostaglandins Leukot Essent Fatty Acids 2001, 65: 229-232 [CrossRef] [PubMed].
  55. Obermeier H, Hrboticky N, Sellmayer A. Differential effects of polyunsaturated fatty acids on cell growth and differentiation of premonocytic U937 cells. Biochim Biophys Acta 1995, 1266: 179-185 [PubMed].
  56. Barceló-Coblijn G, Kitajka K, Puskás LG, Hogyes E, Zvara A, Hackler L Jr, Farkas T. Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochim Biophys Acta 2003, 1632: 72-79 [PubMed].
  57. Han C, Demetris AJ, Michalopoulos G, Shelhamer JH, Wu T. 85-kDa cPLA2 plays a critical role in PPAR-mediated gene transcription in human hepatoma cells. Am J Physiol Gastrointest Liver Physiol 2002, 282: G586-G597 [PubMed].
  58. Mazière C, Conte MA, Degonville J, Ali D, Mazière JC. Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NF$\kappa$B. Biochem Biophys Res Commun 1999, 265: 116-122 [CrossRef] [PubMed].
  59. Becuwe P, Bianchi A, Didelot C, Barberi-Heyob M, Dauca M. Arachidonic acid activates a functional AP-1 and an inactive NF-$\kappa$B complex in human HepG2 hepatoma cells. Free Radical Biol Med 2003, 35: 636-647 [CrossRef].
  60. Tay A, Maxwell P, Li Z, Goldberg H, Skorecki K. Isolation of promoter for cytosolic phospholipase A2 (cPLA2). Biochim Biophys Acta 1994, 1217: 345-347 [PubMed].
  61. Anthonsen MW, Solhaug A, Johansen, B. Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-$\alpha$- and interleukin-1$\beta$-induced NF-$\kappa$B activation. J Biol Chem 2001, 276: 30527-30536 [CrossRef] [PubMed].
  62. Herdegen T, Leah JD. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 1998, 28: 370-490 [PubMed].
  63. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991, 1072: 129-157 [PubMed].
  64. Perisic O, Paterson HF, Mosedale G, Lara-González S, Williams RL. Mapping the phospholipid-binding surface and translocation determinants of the C2 domain from cytosolic phospholipase A2. J Biol Chem 1999, 274: 14979-14987 [CrossRef] [PubMed].
  65. Evans JH, Spencer DM, Zweifach A, Leslie CC. Intracellular calcium signals regulating cytosolic phospholipase A2 translocation to internal membranes. J Biol Chem 2001, 276: 30150-30160 [CrossRef] [PubMed].
  66. Evans JH, Fergus DJ, Leslie CC. Regulation of cytosolic phospholipase A2 translocation. In: Weber G (Ed), Advances in Enzyme Regulation, Vol 43, Pergamon-Elsevier Science Ltd, Kidlington 2003, p 229-244.
  67. Sheridan AM, Sapirstein A, Lemieux N, Martin BD, Kim DK, Bonventre JV. Nuclear translocation of cytosolic phospholipase A2 is induced by ATP depletion. J Biol Chem 2001, 276: 29899-29905 [CrossRef] [PubMed].
  68. Baker RR, Chang HY. Neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor are located in the nuclear envelope and show differential losses in activity. Biochim Biophys Acta Lipids Lipid Metab 1997, 1345: 197-206.
  69. Baker RR, Chang H-Y. Diacylglycerols as sources of arachidonate in isolated neuronal nuclei from cerebral cortex. Biochem Cell Biol 2004, 82: 741-742.
  70. Squinto SP, Block AL, Braquet P, Bazan NG. Platelet-activating factor stimulates a fos/jun/AP-1 transcriptional signaling system in human neuroblastoma cells. J Neurosci Res 1989, 24: 558-566 [CrossRef] [PubMed].
  71. Doucet JP, Squinto SP, Bazan NG. Fos-jun and the primary genomic response in the nervous system. Possible physiological role and pathophysiological significance. Mol Neurobiol 1990, 4: 27-55 [PubMed].
  72. Bazan NG, Packard MG, Teather L, Allan G. Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem Int 1997, 30: 225-231 [CrossRef] [PubMed].
  73. Miguel BG, Calcerrada MC, Martin L, Catalán RE, Martínez AM. Increase of phosphoinositide hydrolysis and diacylglycerol production by PAF in isolated rat liver nuclei. Prostaglandins Other Lipid Mediat 2001, 65: 159-166 [PubMed].
  74. Asano M, Tamiya-Koizumi K, Homma Y, Takenawa T, Nimura Y, Kojima K, Yoshida S. Purification and characterization of nuclear phospholipase C specific for phospho-inositides. J Biol Chem 1994, 269: 12360-12366 [PubMed].
  75. Fukami K. Structure, regulation, and function of phospholipase C isozymes. J Biochem (Tokyo) 2002, 131: 293-299 [PubMed].
  76. Bertagnolo V, Marchisio M, Capitani S, Neri LM. Intranuclear translocation of phospholipase C$\beta$2 during HL-60 myeloid differentiation. Biochem Biophys Res Commun 1997, 235: 831-837 [CrossRef] [PubMed].
  77. Odom AR, Stahlberg A, Wente SR, York JD. A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control. Science 2000, 287: 2026-2029 [CrossRef].
  78. Steger DJ, Haswell ES, Miller AL, Wente SR, O'Shea EK. Regulation of chromatin remodeling by inositol polyphosphates. Science 2003, 299: 114-116 [CrossRef].
  79. Baker, RR, Chang, HY. Alkylglycerophosphate acetyltransferase and lyso platelet activating factor acetyltransferase, two key enzymes in the synthesis of platelet activating factor, are found in neuronal nuclei isolated from cerebral cortex. Biochim Biophys Acta 1996, 1302: 257-263 [PubMed].
  80. Baker RR, Chang H. Substrate specificities of neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor: Differences in the use of 1-alkyl and 1-acyl lysophospholipid acceptors. Biochim Biophys Acta 1998, 1390: 215-224 [PubMed].
  81. Li Y, Maher P, Schubert D. Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proc Natl Acad Sci USA 1998, 95: 7748-7753 [CrossRef] [PubMed].
  82. Ramoni C, Spadaro F, Barletta B, Dupuis ML, Podo F. Phosphatidylcholine-specific phospholipase C in mitogen-stimulated fibroblasts. Exp Cell Res 2004, 299: 370-382 [CrossRef] [PubMed].
  83. Antony P, Farooqui AA, Horrocks LA, Freysz L. Effect of D609 on phosphatidylcholine metabolism in the nuclei of LA-N-1 neuroblastoma cells: a key role for diacylglycerol. FEBS Lett 2001, 509: 115-118 [CrossRef] [PubMed].
  84. Antony P, Kanfer JN, Freysz L. Retinoic acid specifically activates an oleate-dependent phospholipase D in the nuclei of LA-N-1 neuroblastoma cells. FEBS Lett 2003, 541: 93-96 [CrossRef] [PubMed].
  85. Faenza I, Matteucci A, Manzoli L, Billi AM, Aluigi M, Peruzzi D, Vitale M, Castorina S, Suh PG, Cocco L. A role for nuclear phospholipase C$\beta$1 in cell cycle control. J Biol Chem 2000, 275: 30520-30524 [CrossRef] [PubMed].
  86. Lang D, Kanfer JN, Goracci G, Freysz L. Production and function of lipid second messengers in proliferating and differentiated neuroblastoma cells. J Lipid Mediat Cell Signal 1996, 14: 349-359 [CrossRef] [PubMed].
  87. Hozumi Y, Ito T, Nakano T, Nakagawa T, Aoyagi M, Kondo H, Goto K. Nuclear localization of diacylglycerol kinase zeta in neurons. Eur J Neurosci 2003, 18: 1448-1457 [CrossRef] [PubMed].
  88. York JD, Majerus PW. Nuclear phosphatidylinositols decrease during S-phase of the cell cycle in HeLa cells. J Biol Chem 1994, 269: 7847-7850 [PubMed].
  89. Gobeil F Jr, Bernier SG, Vazquez-Tello A, Brault S, Beauchamp MH, Quiniou C, Marrache AM, Checchin D, Sennlaub F, Hou X, Nader M, Bkaily G, Ribeiro-da-Silva A, Goetzl EJ, Chemtob S. Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem 2003, 278: 38875-38883 [CrossRef] [PubMed].
  90. Luquain C, Sciorra VA, Morris AJ. Lysophosphatidic acid signaling: how a small lipid does big things. Trends Biochem Sci 2003, 28: 377-383 [CrossRef] [PubMed].
  91. Banno Y. Regulation and possible role of mammalian phospholipase D in cellular functions. J Biochem (Tokyo) 2002, 131: 301-306 [PubMed].
  92. Kanfer JN, McCartney D, Singh IN, Freysz L. Phospholipase D activity of rat brain neuronal nuclei. J Neurochem 1996, 67: 760-766 [PubMed].
  93. Liscovitch M. Phospholipase D: Role in signal transduction and membrane traffic. J Lipid Mediat Cell Signal 1996, 14: 215-221 [CrossRef] [PubMed].
  94. Miloso M, Villa D, Crimi M, Galbiati S, Donzelli E, Nicolini G, Tredici G. Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent. J Neurosci Res 2004, 75: 241-252 [CrossRef] [PubMed].
  95. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000, 49: 497-505 [CrossRef] [PubMed].
  96. Couturier C, Brouillet A, Couriaud C, Koumanov K, Béréziat G, Andréani M. Interleukin1$\beta$ induces type II-secreted phospholipase A2 gene in vascular smooth muscle cells by a nuclear factor $\kappa$B and peroxisome proliferator-activated receptor-mediated process. J Biol Chem 1999, 274: 23085-23093 [CrossRef] [PubMed].
  97. Jiang YJ, Hatch GM, Mymin D, Dembinski T, Kroeger EA, Choy PC. Modulation of cytosolic phospholipase A2 by PPAR activators in human preadipocytes. J Lipid Res 2001, 42: 716-724 [PubMed].
  98. Alaoui-El-Azher M, Wu Y, Havet N, Israel A, Lilienbaum A, Touqui L. Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA2-IIA expression in alveolar macrophages through NF-$\kappa$B and PPAR-$\gamma$-dependent pathways. Mol Pharmacol 2002, 61: 786-794 [CrossRef] [PubMed].
  99. Petroni A, Blasevich M, Papini N, La Spada P, Galli C. Changes in arachidonic acid levels and formation and in lipid synthesis in the human neuroblastoma SK-N-BE during retinoic acid-induced differentiation. J Neurochem 1996, 67: 549-556 [PubMed].
  100. Ishihara H, Tamiya-Koizumi K, Kuriki H, Yoshida S, Kojima K. Growth-associated changes in fatty acid compositions of nuclear phospholipids of liver cells. Biochim Biophys Acta 1991, 1084: 53-59 [PubMed].
  101. Lee JY, Hwang DH. Docosahexaenoic acid suppresses the activity of peroxisome proliferator-activated receptors in a colon tumor cell line. Biochem Biophys Res Commun 2002, 298: 667-674 [CrossRef] [PubMed].
  102. Yu K, Bayona W, Kallen CB, Harding HP, Ravera CP, McMahon G, Brown M, Lazar MA. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 1995, 270: 23975-23983 [CrossRef] [PubMed].
  103. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-$\Delta$12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR$\gamma$. Cell 1995, 83: 803-812 [CrossRef] [PubMed].
  104. Rosen ED, Spiegelman BM. PPAR$\gamma$: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001, 276: 37731-37734 [PubMed].
  105. Farooqui AA, Hirashima Y, Horrocks LA. Brain phospholipases and their role in signal transduction. In: Bazan NG, Toffano G, Murphy M (Eds), Neurobiology of Essential Fatty Acids, Plenum Press, New York 1992, p 11-25.
  106. Clark JD, Schievella AR, Nalefski EA, Lin L-L. Cytosolic phospholipase A2. J Lipid Mediat Cell Signal 1995, 12: 83-117 [CrossRef] [PubMed].
  107. Klein J, Chalifa V, Liscovitch M, Löffelholz K. Role of phospholipase D activation in nervous system physiology and pathophysiology. J Neurochem 1995, 65: 1445-1455 [PubMed].
  108. Farooqui AA, Horrocks LA. Methods for the determination of phospholipases, lipases and lysophospholipases. In: Boulton AA, Baker GB, Horrocks LA (Eds), Neuromethods, Vol 7, Lipids and Related Compounds, Humana Press, New Jersey 1988, p 179-209.
  109. Baker RR, Chang HY. The acylation of 1-acyl-sn-glycero-3-phosphate by neuronal nuclei and microsomal fractions of immature rabbit cerebral cortex. Biochem Cell Biol 1990, 68: 641-647 [PubMed].
  110. Baker RR, Chang H. Phosphatidylinositol synthetase activities in neuronal nuclei and microsomal fractions isolated from immature rabbit cerebral cortex. Biochim Biophys Acta 1990, 1042: 55-61 [PubMed].
  111. Morand JN, Kent C. Localization of the membrane-associated CTP:phosphocholine cytidylyltransferase in Chinese hamster ovary cells with an altered membrane composition. J Biol Chem 1989, 264: 13785-13792 [PubMed].
  112. Baker RR, Chang HY. The incorporation of fatty acids into triacylglycerols of isolated neuronal nuclear envelopes: the influence of thiol reducing reagents and chromatin. Biochim Biophys Acta 1987, 920: 285-292 [PubMed].
  113. Payrastre B, Nievers M, Boonstra J, Breton M, Verkleij AJ, van Bergen en Henegouwen PM. A differential location of phosphoinositide kinases, diacylglycerol kinase, and phospholipase C in the nuclear matrix. J Biol Chem 1992, 267: 5078-5084 [PubMed].
  114. Kleuser B, Maceyka M, Milstien S, Spiegel S. Stimulation of nuclear sphingosine kinase activity by platelet-derived growth factor. FEBS Lett 2001, 503: 85-90 [CrossRef] [PubMed].
  115. Albi E, Viola MM. Phosphatidylcholine-dependent phospholipase C in rat liver chromatin. Biochem Biophys Res Commun 1999, 265: 640-643 [CrossRef] [PubMed].
  116. Tamiya-Koizumi K, Umekawa H, Yoshida S, Ishihara H, Kojima K. A novel phospholipase A2 associated with nuclear matrix: stimulation of the activity and modulation of the Ca2+-dependency by polyphosphoinositides. Biochim Biophys Acta 1989, 1002: 182-188 [PubMed].
  117. Fernández-Tome M, Kraemer L, Federman SC, Favale N, Speziale E, Sterin-Speziale N. COX-2-mediated PG2 synthesis regulates phosphatidylcholine biosynthesis in rat renal papillary tissue. Biochem Pharmacol 2004, 67: 245-254 [CrossRef] [PubMed].